---
title: "Longshenrongfa Pharmaceutical Industry: Obtained the drug production license after renewal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252633338.md"
description: "On the evening of August 12, Longshenrongfa Pharmaceutical Industry announced that the company recently obtained the \"Drug Manufacturing License\" approved by the Gansu Provincial Drug Administration and the \"Drug GMP Compliance Inspection Notification.\" The change in the \"Drug Manufacturing License\" is mainly due to the company's addition of the production scope for the processing and roasting of traditional Chinese medicine pieces. At the same time, the company passed the drug GMP compliance inspection, indicating that the company's production line for processing and roasting traditional Chinese medicine pieces meets the requirements of the \"Drug Production Quality Management Standards,\" which is beneficial for enriching the company's product production line and optimizing the product structure"
datetime: "2025-08-12T08:59:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252633338.md)
  - [en](https://longbridge.com/en/news/252633338.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252633338.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry: Obtained the drug production license after renewal

Longshenrongfa Pharmaceutical Industry announced on the evening of August 12 that the company has recently obtained the "Drug Manufacturing License" approved by the Gansu Provincial Drug Administration and the issued "Drug GMP Compliance Inspection Notification." The change in the "Drug Manufacturing License" is mainly due to the company's addition of the production scope for the processing and roasting of traditional Chinese medicine pieces. At the same time, the company has passed the drug GMP compliance inspection, indicating that the company's production line for processing and roasting traditional Chinese medicine pieces meets the requirements of the "Drug Production Quality Management Standards," which is beneficial for enriching the company's product line and optimizing the product structure

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [Luvme Hair Sets a New Standard for "Good Hair" at NYFW, Bringing Originalive™ to the SHOWPONY SS27 Runway](https://longbridge.com/en/news/298763269.md)
- [Climeworks says upgraded Mammoth units more than double CO₂ capture performance](https://longbridge.com/en/news/298546691.md)
- [Denarius Metals secures option for up to 28 Toral West mining claims in Spain](https://longbridge.com/en/news/298445344.md)
- [Definium Therapeutics to present Phase 3 topline data for DT120 in MDD, GAD at Psych Congress 2026](https://longbridge.com/en/news/298582158.md)
- [CGN Releases Next-Gen of China’s Self-Developed Hualong One Nuclear Power Technology](https://longbridge.com/en/news/298274270.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**